glp 1 agonist oral Orforglipron, an Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes Oral GLP-1s rapidly expanding user

In view of the rapid development of GSH-responsive and -exhausting metal nanomedicines in potentiating cancer therapy, we summarize and outline the recent advancements, mechanisms, prospects, and challenges in this field from different strategies (Scheme 1)

Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon-like peptide-1 on glomeruli and tubules in diabetic rats

Combining NAD+ and glutathione may support energy production, detox pathways, and metabolic health

Individuals often experience a general improvement in their overall wellness, which can contribute to better weight control

Caradonna et al., 2024)